Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001437749-11-009085
Filing Date
2011-11-30
Accepted
2011-11-30 12:34:16
Documents
7
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A calypte_10qa-063011.htm 10-Q/A 32916
  Complete submission text file 0001437749-11-009085.txt   2276200

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE cbmc-20110630.xml EX-101.INS 511946
3 XBRL TAXONOMY EXTENSION SCHEMA cbmc-20110630.xsd EX-101.SCH 15547
4 XBRL TAXONOMY EXTENSION CALCULATION cbmc-20110630_cal.xml EX-101.CAL 24187
5 XBRL TAXONOMY EXTENSION DEFINITION cbmc-20110630_def.xml EX-101.DEF 75890
6 XBRL TAXONOMY EXTENSION LABELS cbmc-20110630_lab.xml EX-101.LAB 105161
7 XBRL TAXONOMY EXTENSION PRESENTATION cbmc-20110630_pre.xml EX-101.PRE 87072
Mailing Address 5000 HOPYARD ROAD, SUITE 480 PLEASANTON CA 94588
Business Address 5000 HOPYARD ROAD, SUITE 480 PLEASANTON CA 94588 9257307200
CALYPTE BIOMEDICAL CORP (Filer) CIK: 0000899426 (see all company filings)

EIN.: 061226727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-32280 | Film No.: 111233269
SIC: 3826 Laboratory Analytical Instruments